Jasvinder A Singh1, Shaohua Yu2. 1. From the Medicine Service, Birmingham Veterans Affairs (VA) Medical Center; Department of Medicine at the School of Medicine, and Division of Epidemiology at the School of Public Health, University of Alabama at Birmingham (UAB), Birmingham, Alabama; Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.J.A. Singh, MBBS, MPH, Medicine Service, Birmingham VA Medical Center, and the Department of Medicine at the School of Medicine, and Division of Epidemiology at the School of Public Health, UAB; and the Department of Orthopedic Surgery, Mayo Clinic College of Medicine; S. Yu, MS, Department of Medicine at the School of Medicine, and the Division of Epidemiology at the School of Public Health, UAB. Jasvinder.md@gmail.com. 2. From the Medicine Service, Birmingham Veterans Affairs (VA) Medical Center; Department of Medicine at the School of Medicine, and Division of Epidemiology at the School of Public Health, University of Alabama at Birmingham (UAB), Birmingham, Alabama; Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.J.A. Singh, MBBS, MPH, Medicine Service, Birmingham VA Medical Center, and the Department of Medicine at the School of Medicine, and Division of Epidemiology at the School of Public Health, UAB; and the Department of Orthopedic Surgery, Mayo Clinic College of Medicine; S. Yu, MS, Department of Medicine at the School of Medicine, and the Division of Epidemiology at the School of Public Health, UAB.
Abstract
OBJECTIVE: To assess gout-related emergency department (ED) use/charges and discharge disposition. METHODS: We used the US National ED Sample (NEDS) data to examine the time trends in total ED visits and charges and ED-related hospitalizations with gout as the primary diagnosis. We assessed multivariable-adjusted predictors of ED charges and hospitalization for gout-related visits using the 2012 NEDS data. RESULTS: There were 180,789, 201,044, and 205,152 ED visits in 2009, 2010, and 2012 with gout as the primary diagnosis, with total ED charges of $195 million, $239 million, and $287 million, respectively; these accounted for 0.14%-0.16% of all ED visits. Mean/median 2012 ED charges/visit were $1398/$956. Of all gout-related ED visits, 7.7% were admitted to the hospital in 2012. Mean/median length of hospital stay was 3.9/2.6 days and mean/median inpatient charge/admission with gout as the primary diagnosis was $22,066/$15,912 in 2012. In multivariable-adjusted analyses, these factors were associated with higher ED charges: older age, female sex, highest income quartile, being uninsured, metropolitan residence, Western United States hospital location, heart disease, renal failure, heart failure, hypertension (HTN), diabetes, osteoarthritis (OA), and chronic obstructive pulmonary disease (COPD). These factors were associated with higher odds of hospitalization: older age, Northeast location, metropolitan teaching hospital, higher income quartile, heart disease, renal failure, heart failure, hyperlipidemia, HTN, diabetes, COPD, and OA, whereas self-pay insurance status was associated with lower odds of hospitalization, following an ED visit for gout. CONCLUSION: Absolute ED use and charges for gout increased over time, but relative use remained stable. Modifiable comorbidity factors associated with higher gout-related use should be targeted to reduce morbidity and healthcare use.
OBJECTIVE: To assess gout-related emergency department (ED) use/charges and discharge disposition. METHODS: We used the US National ED Sample (NEDS) data to examine the time trends in total ED visits and charges and ED-related hospitalizations with gout as the primary diagnosis. We assessed multivariable-adjusted predictors of ED charges and hospitalization for gout-related visits using the 2012 NEDS data. RESULTS: There were 180,789, 201,044, and 205,152 ED visits in 2009, 2010, and 2012 with gout as the primary diagnosis, with total ED charges of $195 million, $239 million, and $287 million, respectively; these accounted for 0.14%-0.16% of all ED visits. Mean/median 2012 ED charges/visit were $1398/$956. Of all gout-related ED visits, 7.7% were admitted to the hospital in 2012. Mean/median length of hospital stay was 3.9/2.6 days and mean/median inpatient charge/admission with gout as the primary diagnosis was $22,066/$15,912 in 2012. In multivariable-adjusted analyses, these factors were associated with higher ED charges: older age, female sex, highest income quartile, being uninsured, metropolitan residence, Western United States hospital location, heart disease, renal failure, heart failure, hypertension (HTN), diabetes, osteoarthritis (OA), and chronic obstructive pulmonary disease (COPD). These factors were associated with higher odds of hospitalization: older age, Northeast location, metropolitan teaching hospital, higher income quartile, heart disease, renal failure, heart failure, hyperlipidemia, HTN, diabetes, COPD, and OA, whereas self-pay insurance status was associated with lower odds of hospitalization, following an ED visit for gout. CONCLUSION: Absolute ED use and charges for gout increased over time, but relative use remained stable. Modifiable comorbidity factors associated with higher gout-related use should be targeted to reduce morbidity and healthcare use.
Entities:
Keywords:
CHARGES; EMERGENCY ROOM; GOUT; HEALTHCARE USE; HOSPITALIZATION; INPATIENT USE
Authors: Chaitanya A Sarawate; Kathleen K Brewer; Wenya Yang; Pankaj A Patel; H Ralph Schumacher; Kenneth G Saag; Alan W Bakst Journal: Mayo Clin Proc Date: 2006-07 Impact factor: 7.616
Authors: Joseph J Saseen; Neetu Agashivala; Richard Read Allen; Vahram Ghushchyan; Anthony M Yadao; Kavita V Nair Journal: Rheumatology (Oxford) Date: 2012-07-23 Impact factor: 7.580
Authors: Florian Roghmann; Khurshid R Ghani; Keith J Kowalczyk; Naeem Bhojani; Jesse D Sammon; Giorgio Gandaglia; Vincent Trudeau; Andreas Becker; Shyam Sukumar; Mani Menon; Kevin C Zorn; Pierre Karakiewicz; Maxine Sun; Joachim Noldus; Quoc-Dien Trinh Journal: J Urol Date: 2013-06-11 Impact factor: 7.450
Authors: Jasvinder A Singh; Kenneth G Saag; S Louis Bridges; Elie A Akl; Raveendhara R Bannuru; Matthew C Sullivan; Elizaveta Vaysbrot; Christine McNaughton; Mikala Osani; Robert H Shmerling; Jeffrey R Curtis; Daniel E Furst; Deborah Parks; Arthur Kavanaugh; James O'Dell; Charles King; Amye Leong; Eric L Matteson; John T Schousboe; Barbara Drevlow; Seth Ginsberg; James Grober; E William St Clair; Elizabeth Tindall; Amy S Miller; Timothy McAlindon Journal: Arthritis Rheumatol Date: 2015-11-06 Impact factor: 10.995
Authors: John D Osborne; James S Booth; Tobias O'Leary; Amy Mudano; Giovanna Rosas; Phillip J Foster; Kenneth G Saag; Maria I Danila Journal: AMIA Annu Symp Proc Date: 2021-01-25
Authors: Dena H Jaffe; Alyssa B Klein; Arriel Benis; Natalia M Flores; Hagit Gabay; Robert Morlock; Dana Y Teltsch; Jonathan Chapnick; Yair Molad; Shmuel M Giveon; Becca Feldman; Maya Leventer-Roberts Journal: BMC Rheumatol Date: 2019-03-19
Authors: Ted R Mikuls; Quint Soto; Alison Petro; Lindsay Helget; Punyasha Roul; Harlan Sayles; Brendan Cope; Tuhina Neogi; Brian LaMoreaux; James R O'Dell; Bryant R England Journal: JAMA Netw Open Date: 2022-01-04